-
-
-
-
-
-
-
Atea Pharmaceuticals' (AVIR) Board of Directors Unanimously Rejects Unsolicited Proposal from Tang Capital Partners’ Affiliate, Concentra Biosciences
-
-
-
-
-
-
-
Aviragen Adjourns Special Meeting of Stockholders to Allow Stockholders to Consider Improved Merger Deal Terms
-
-
-
-
-
-
-
Vaxart Announces Its Oral Flu Vaccine Significantly Reduced Rate of Influenza Infection in Phase 2 Challenge Study
-
-
-
-
-
-
-
Aviragen Comments on ISS Report
-
-
-
-
-
-
-
Aviragen Board Of Directors Unanimously Recommends That Stockholders Vote FOR The Proposed Merger With Vaxart
-
-
-
-
-
-
-
Aviragen Therapeutics (AVIR) Hires Stifel to Review Strategic Alternatives
-
-
-
1,155,058 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

